Skip to main content
SpringerLink
Log in

Impaired bone formation in male idiopathic osteoporosis: Further reduction in the presence of concomitant hypercalciuria

  • Original Article
  • Published:
Osteoporosis International Aims and scope Submit manuscript

Abstract

We present iliac bone histomorphometric data and related biochemical data from 16 nonalcoholic men (50±11 (SD) years) referred for evaluation of spontaneous skeletal and/or appendicular fractures and reduced spinal bone density. All men were eugonadal and had no known underlying disorder associated with osteopenia. For the group, mean serum chemistry values were within normal limits including immunoreactive parathyroid hormone, osteocalcin and serum 1,25-dihydroxyvitamin D [1,25(OH)2D]. Nine men demonstrated hypercalciuria (⩾0.1 mmol/kg per day) while on a constant metabolic diet of 20 mmol/day Ca. Their 24-hour urinary calcium was significantly greater than that for the remaining 7 men (7.4±1.6 vs. 5.0±0.8 mmol/day,p=0.003), as was their calciuric response to a 1 g oral calcium load (0.23±0.06 vs. 0.15±0.05 Ca/creatinine,p=0.042). Serum parameters (including parathyroid hormone and 1,25(OH)2D) of hypercal-ciuric and normocalciuric men were not significantly different. Histomorphometric indices for cancellous bone demonstrated significant differences between the entire group of osteoporotic men and age-adjusted normal values for bone volume (11.4±4.0% vs. 23.2±4.4%), osteoid surface (5.6±3.9% vs. 12.1±4.6%), osteoblastic surface (2.0±2.3% vs. 3.9±1.9%), and mineralizing surface (1.9±2.4% vs. 5.1±2.7%);there were also significant differences in bone formation rate (total surface referent) (0.004±0.001 vs. 0.011±0.006 mm3/mm2 per year). Compared with the normocalciuric group the 9 hypercalciuric men had significantly lower osteoblastic surfaces (1.6±1.9% vs. 2.5±2.6%) and mineralizing surfaces (1.4±1.5% vs. 2.7±3.2%). Cortical bone indices demonstrated a similar trend in formation parameters although these differences did not reach significance. These results suggest that idiopathic osteoporosis in men is characterized by suppressed bone formation due to reduced osteoblast proliferation and that this defect is exaggerated in hypercalciuric men as opposed to normocalciuric men. The cause for suppressed bone formation and increased intestinal absorption of calcium in some men is not known but may be the result of 1,25(OH)2D or some previously unrecognized factor(s).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Francis RM, Peacock M, Aaron JE et al. Osteoporosis in hypogonadal men: role of decreased plasma 1,25-dihydroxyvitamin D, calcium malabsorption, and low bone formation. Bone 1986; 7:261–8.

    Google Scholar 

  2. Greenspan SL, Neer RM, Ridgway EC, Kilbanski A. Osteoporosis in men with hyperprolactinemic hypogonadism. Ann Intern Med 1986; 104:777–82.

    Google Scholar 

  3. Seeman E, Melton III, LJ, O'Fallon WM, Riggs BL. Risk factors for spinal osteoporosis in men. Am J Med 1983; 75:977–83.

    Google Scholar 

  4. De Vernejoul MC, Bielakoff J, Herve M et al. Evidence for defective osteoblastic function. A role for alcohol and tobacco consumption in osteoporosis in middle-aged men. Clin Orthop Rel Res 1983; 179:107–15.

    Google Scholar 

  5. Jackson WPU. Osteoporosis of unknown cause in younger people. J Bone Joint Surg 1958; 40B:420–41

    Google Scholar 

  6. Parfitt AM, Duncan H. Metabolic bone disease affecting the spine. In: Rothman R, Simeone F, editors. The spine, 2nd edn. Philadelphia: Saunders, 1982: 775–905.

    Google Scholar 

  7. Bordier PJ, Miravet L, Hioco D. Young adult osteoporosis. Clin Endocrinol Metab 1973; 2:277–92.

    Google Scholar 

  8. Hioco D, Miravet L, Bordier P. Physiopathology and treatment of osteoporosis in younger men. In: Blackwood HM, (editor). Bone and tooth. Oxford: Pergamon Press, 1964; 365–97.

    Google Scholar 

  9. Perry HM, Fallon MD, Bergfield M, Teitelbaum SL, Avioli LV. Osteoporosis in young men: a syndrome of hypercalciuria and accelerated bone turnover. Arch Intern Med 1982; 142: 1295–8.

    Google Scholar 

  10. Baran DT, Bergfield MA, Teitelbaum SL, Avioli LV. Effect of testosterone therapy on bone formation in an osteoporotic hypogonadal male. Calcif Tissue Res 1978; 26:103–6.

    Google Scholar 

  11. Jackson JA, Kleerekoper M, Parfitt AM, Rao DS, Villanueva AR, Frame B. Bone histomorphometry in hypogonadal and eugonadal men with spinal osteoporosis. J Clin Endocrinol Metab 1987; 65:53–8.

    Google Scholar 

  12. Breslau NA, Zerwekh JE, Nicar MJ, Pak CYC. Effects of short-term glucocorticoid administration in primary hyperparathyroidism:comparison to sarcoidosis. J Clin Endocrinol Metab 1982; 54:824–30.

    Google Scholar 

  13. Zerwekh JE, Marks SC, Jr, McGuire JL. Elevated serum 1,25-dihydroxyvitamin D in osteopetrotic mutations in three species. Bone Miner 1987; 2:193–9.

    Google Scholar 

  14. Kivirikko KI, Laitinen O, Prockop DJ. Modifications of a specific assay for hydroxyproline in urine. Anal Biochem 1967; 19:249–55.

    Google Scholar 

  15. Pak CYC, Ohata M, Lawrence ED, Snyder W. The hypercal-ciurias: causes, parathyroid functions and diagnostic criteria. J Clin Invest 1974; 54:387–400.

    Google Scholar 

  16. Pak CYC, Kaplan R, Bone H, Townsend J, Waters O. A simple test for the diagnosis of absorptive, resorptive and renal hypercal-ciurias. N Engl J Med 1975; 292:497–500.

    Google Scholar 

  17. Parfitt AM, Podenphant J, Villanueva AR, Frame B. Metabolic bone disease with and without osteomalacia after intestinal bypass surgery: a bone histomorphometric study. Bone 1985; 6:211–20.

    Google Scholar 

  18. Recker RR, Kimmel DB, Parfitt AM, Davies KM, Keshawarz N, Hinders S. Static and tetracycline-based bone histomorphometric data from 34 normal postmenopausal females. J Bone Miner Res 1988; 3:133–44.

    Google Scholar 

  19. Vedi S, Compston JE, Webb A, Tighe JR. Histomorphometric analysis of dynamic trabecular bone formation in the iliac crest of normal British subjects. Metab Bone Dis Rel Res 1983; 5:69–74.

    Google Scholar 

  20. Horsman A, Nordin BEC, Gallagher JC, Kirby PA, Milner RM, Simpson M. Observation of sequential changes in bone mass in postmenopausal women: a controlled trial of estrogens and calcium carbonate on bone loss in postmenopausal women. Calcif Tissue Res. 1977; 22 [Suppl]:217–224.

    Google Scholar 

  21. Lindsay R, Aitken JM, Anderson JB, Hart DM, MacDonald EB, Clarke AC. Long-term prevention of postmenopausal osteoporosis by estrogen: evidence for increased bone mass after delayed onset of estrogen treatment. Lancet 1976; 1:1038–41.

    Google Scholar 

  22. Riggs BL, Wahner WL, Dunn WL, Mazess RB, Offord KP, Melton LJ, III. Differential changes in bone mineral density of the appendicular and axial skeleton with aging. J Clin Invest 1981; 67:328–35.

    Google Scholar 

  23. Norman DA, Fordtran JS, Brinkley LJ et al. Jejunal and ileal adaptation to alterations in dietary calcium: changes in calcium and magnesium absorption and pathogenetic role of parathyroid hormone and 1,25-dihydroxyvitamin D. J Clin Invest 1981; 67:1599–603.

    Google Scholar 

  24. Insogna KL, Broadus AE, Dreyer BE, Ellison AF, Gertner JM. Elevated production rate of 1,25-dihydroxyvitamin D in patients with absorptive hypercalciuria. J Clin Endocrinol Metab 1985; 61:490–5.

    Google Scholar 

  25. Malluche HH, Tschoepe W, Ritz E, Meyer-Sabellek W, Massry SG. Abnormal bone histology in idiopathic hypercalciuria. J Clin Endocrinol Metab 1980; 50:654–8.

    Google Scholar 

  26. Parfitt AM. The physiological and clinical significance of bone histomorphometric data. In: Recker RR, edtior. Bone histomorphometry: techniques and interpretation. Boca Raton, Florida: CRC Press, 1983:143–223.

    Google Scholar 

  27. Canalis E, McCarthy T, Centrella M. Growth factors and the regulation of bone remodeling. J Clin Invest 1988; 81:277–81.

    Google Scholar 

  28. Chen TL, Cone CM, Feldman D. Effects of 1α,25-dihydroxy-vitamin D3 and glucocorticoids on the growth of rat and mouse osteoblast-like bone cells. Calcif Tissue Int 1983; 35:806–11.

    Google Scholar 

  29. Raisz LG, Kream BE, Smith MD, Simmons HA. Comparison of the effects of vitamin D metabolites on collagen synthesis and resorption of fetal rat bone in organ culture. Calcif Tissue Int 1980; 32:135–8.

    Google Scholar 

  30. Raisz LG, Maina DM, Gworek SC, Dietrich JW, Canalis EM. Hormonal control of bone collagen synthesis in vitro: inhibitory effects of 1-hydroxylated vitamin D metabolites. Endocrinology 1978; 102:731–5.

    Google Scholar 

  31. Malluche HH, Farigere MC, Friedler RM, Fanti P. 1,25-Dihyd-roxyvitamin D3 corrects bone loss but suppresses bone remodeling in ovariohysterectomized beagle dogs. Endocrinology 1988; 122:1998–2006.

    Google Scholar 

  32. Pacifici R, Rifas L, Teitelbaum S et al. Spontaneous release of interleukin-1 from human blood monocytes reflects bone formation in idiopathic osteoporosis. Proc Natl Acad Sci USA 1987; 84:4616–20.

    Google Scholar 

  33. Pacifici R, Ruthstein M, Rifas L et al. Increased interleukin-1 activity and decreased bone density in patients with fasting hypercalciuria (FH). Urol Res 1988; 16:218 (abstr).

    Google Scholar 

  34. Gowen M, Wood DD, Russell RGG. Stimulation of the proliferation of human bone cells in vitro by human monocyte products with interleukin-1 activity. J Clin Invest 1985; 75:1223–9.

    Google Scholar 

  35. Parfitt AM, Drezner MK, Glorieux FH et al. Histomorphometry: Standardization of nomenclature, symbols and units. J Bone Miner Res 1987; 2:595–610.

    Google Scholar 

  36. Frost HM (1969) Tetracycline-based histological analysis of bone remodeling. Calcif Tissue Res 1969; 3:211–37.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Center for Mineral Metabolism and Clinical Research, University of Texas Southwestern Medical School, 75235-8885, Dallas, Texas, USA

    J. E. Zerwekh, K. Sakhaee, N. A. Breslau & C. Y. C. Pak

  2. Department of Orthopedic Surgery, University of Texas Southwestern Medical School, Dallas, Texas, USA

    F. Gottschalk

Authors
  1. J. E. Zerwekh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K. Sakhaee
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. N. A. Breslau
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. F. Gottschalk
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. C. Y. C. Pak
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zerwekh, J.E., Sakhaee, K., Breslau, N.A. et al. Impaired bone formation in male idiopathic osteoporosis: Further reduction in the presence of concomitant hypercalciuria. Osteoporosis Int 2, 128–134 (1992). https://doi.org/10.1007/BF01623819

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01623819

Keywords

Search

Navigation